Cannabis Use Disorder and Opioid Health Risks in Veterans: A Long-Term VA Study

Who could benefit from this research

What this research studies

This project follows adult Veterans Affairs patients over time to understand how cannabis use disorder affects opioid-related hospitalizations, overdoses, and treatment outcomes. It will examine whether receiving treatment for cannabis use disorder changes these opioid-related risks. Researchers will analyze medical records from the VA to identify patterns and potential protective or harmful effects of CUD treatment on opioid health outcomes. The study aims to inform policies and care approaches within the VA to improve safety and health for people with both conditions.

Why it matters

Where this research is happening

• Columbia University Health Sciences
  New York, United States Active

Researchers

• Principal investigator: Mannes, Zachary L — Columbia University Health Sciences
• Study coordinator: Mannes, Zachary L

Related research

Other NIH-funded projects on the same topics.

• Hemp-derived CBD for reducing cannabis use in high-THC concentrate users

  A randomized, placebo-controlled trial tests whether hemp-derived CBD can help adults who mainly use high-potency cannabis concentrates reduce their cannabis use.

  NIH research University of Colorado · Boulder, UNITED STATES · NIH-11567759

• Varenicline for Cannabis Use Disorder in Men and Women

  A clinical trial will test if varenicline helps people with cannabis use disorder, with a focus on differences between men and women and added counseling to support craving and mood management.

  NIH research Medical University of South Carolina · Charleston, United States · NIH-11445421

• One-session computerized program with text reminders to help manage distress and reduce cannabis use

  A short computer-delivered emotional skills session plus just-in-time text reminders to help people who use cannabis and struggle with handling distress learn to tolerate emotions and cut back on use.

  NIH research Florida State University · Tallahassee, United States · NIH-11399242

• Advancing Pregnenolone as a Therapy for Cannabis Use Disorder with Depression

  A study tests pregnenolone as a therapy for adults who have both cannabis use disorder and depression and aims to reduce cannabis use and improve mood.

  NIH research Ut Southwestern Medical Center · Dallas, United States · NIH-11392064

• Cannabis use and HIV: how pot may affect aging and HIV outcomes

  A big study will look at how cannabis use and cannabis use disorder affect older people with HIV, including how it relates to aging problems and HIV treatment success.

  NIH research Boston University Medical Campus · Boston, United States · NIH-11371946

• Hemp-derived CBD for helping people reduce high-potency cannabis use

  A clinical trial tests whether hemp-derived CBD can help adults reduce cannabis use and related withdrawal and mood symptoms when using high-potency cannabis concentrates.

  NIH research University of Colorado · Boulder, UNITED STATES · NIH-11361074

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.